Condition
Respiratory Viruses
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Terminated1
Recruiting1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07287137Phase 4Active Not Recruiting
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
NCT07156890RecruitingPrimary
Surveillance of Respiratory Viruses in Healthcare and Animal Workers
NCT01597089TerminatedPrimary
Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
Showing all 3 trials